Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 26 | 2025 | 2218 | 3.800 |
Why?
|
| Brain Mapping | 9 | 2024 | 234 | 2.300 |
Why?
|
| Glioma | 4 | 2022 | 100 | 2.020 |
Why?
|
| Meningomyelocele | 8 | 2010 | 11 | 1.690 |
Why?
|
| Brain Neoplasms | 6 | 2024 | 313 | 1.540 |
Why?
|
| Neuroimaging | 7 | 2025 | 155 | 1.310 |
Why?
|
| Language Disorders | 5 | 2009 | 25 | 1.090 |
Why?
|
| Brain | 11 | 2025 | 1581 | 1.030 |
Why?
|
| Hydrocephalus | 6 | 2005 | 43 | 0.980 |
Why?
|
| Nerve Net | 3 | 2020 | 99 | 0.930 |
Why?
|
| Virus Diseases | 2 | 2016 | 123 | 0.870 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2016 | 1670 | 0.850 |
Why?
|
| Back Pain | 1 | 2023 | 51 | 0.790 |
Why?
|
| Diagnostic Imaging | 3 | 2016 | 266 | 0.770 |
Why?
|
| Sensorimotor Cortex | 1 | 2022 | 4 | 0.760 |
Why?
|
| Cerebellum | 1 | 2022 | 95 | 0.720 |
Why?
|
| Cerebral Cortex | 1 | 2022 | 267 | 0.670 |
Why?
|
| Brain Diseases | 3 | 2021 | 78 | 0.650 |
Why?
|
| Ovarian Neoplasms | 1 | 2021 | 155 | 0.640 |
Why?
|
| Humans | 47 | 2025 | 64272 | 0.570 |
Why?
|
| Prefrontal Cortex | 1 | 2019 | 123 | 0.550 |
Why?
|
| Social Environment | 2 | 2009 | 93 | 0.510 |
Why?
|
| Parasitic Diseases | 1 | 2016 | 6 | 0.500 |
Why?
|
| Laryngoplasty | 1 | 2016 | 1 | 0.500 |
Why?
|
| Vocal Cord Paralysis | 1 | 2016 | 10 | 0.490 |
Why?
|
| Mycoses | 1 | 2016 | 47 | 0.480 |
Why?
|
| Language | 4 | 2024 | 150 | 0.470 |
Why?
|
| Algorithms | 3 | 2017 | 1029 | 0.470 |
Why?
|
| Orbit | 1 | 2015 | 16 | 0.470 |
Why?
|
| Neoplasms | 2 | 2023 | 1393 | 0.470 |
Why?
|
| Bone Diseases | 1 | 2015 | 23 | 0.460 |
Why?
|
| Family | 2 | 2009 | 243 | 0.460 |
Why?
|
| Eye Diseases | 1 | 2015 | 36 | 0.460 |
Why?
|
| Spinal Dysraphism | 3 | 2005 | 18 | 0.450 |
Why?
|
| Male | 32 | 2025 | 30322 | 0.450 |
Why?
|
| Prion Diseases | 1 | 2014 | 10 | 0.440 |
Why?
|
| Central Nervous System Infections | 1 | 2014 | 8 | 0.440 |
Why?
|
| Bacterial Infections | 1 | 2016 | 153 | 0.440 |
Why?
|
| Female | 31 | 2025 | 33383 | 0.440 |
Why?
|
| Temperament | 2 | 2004 | 19 | 0.430 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2015 | 186 | 0.420 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2014 | 181 | 0.420 |
Why?
|
| Radiation Protection | 1 | 2013 | 26 | 0.400 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2013 | 32 | 0.400 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2013 | 75 | 0.390 |
Why?
|
| Child | 17 | 2025 | 4583 | 0.390 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 194 | 0.380 |
Why?
|
| Radiation Dosage | 1 | 2013 | 138 | 0.380 |
Why?
|
| Head and Neck Neoplasms | 1 | 2013 | 167 | 0.360 |
Why?
|
| Central Nervous System Neoplasms | 2 | 2024 | 39 | 0.360 |
Why?
|
| Emergency Medical Services | 1 | 2015 | 267 | 0.350 |
Why?
|
| Critical Care | 1 | 2015 | 402 | 0.350 |
Why?
|
| Cysts | 1 | 2011 | 43 | 0.340 |
Why?
|
| Adult | 15 | 2025 | 17136 | 0.320 |
Why?
|
| Frontal Lobe | 2 | 2021 | 64 | 0.320 |
Why?
|
| Liver Diseases | 1 | 2011 | 160 | 0.310 |
Why?
|
| Ventriculoperitoneal Shunt | 3 | 2003 | 31 | 0.300 |
Why?
|
| Language Tests | 3 | 2005 | 39 | 0.300 |
Why?
|
| Stroke | 2 | 2015 | 1196 | 0.290 |
Why?
|
| Radiosurgery | 2 | 2020 | 69 | 0.290 |
Why?
|
| Child, Preschool | 9 | 2025 | 2019 | 0.290 |
Why?
|
| Genetic Therapy | 2 | 2025 | 799 | 0.280 |
Why?
|
| Cerebrospinal Fluid Shunts | 3 | 2005 | 10 | 0.270 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2025 | 677 | 0.260 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 3 | 2020 | 155 | 0.260 |
Why?
|
| Middle Aged | 12 | 2024 | 17923 | 0.250 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2006 | 5 | 0.250 |
Why?
|
| Limbic System | 1 | 2006 | 27 | 0.250 |
Why?
|
| Abnormalities, Multiple | 1 | 2006 | 54 | 0.240 |
Why?
|
| Rest | 3 | 2020 | 46 | 0.240 |
Why?
|
| Child Language | 1 | 2005 | 10 | 0.230 |
Why?
|
| Retrospective Studies | 8 | 2024 | 6741 | 0.230 |
Why?
|
| Gray Matter | 1 | 2025 | 38 | 0.230 |
Why?
|
| Gangliosidoses, GM2 | 1 | 2025 | 19 | 0.230 |
Why?
|
| Sandhoff Disease | 1 | 2025 | 36 | 0.230 |
Why?
|
| Memory | 1 | 2006 | 123 | 0.230 |
Why?
|
| Tay-Sachs Disease | 1 | 2025 | 46 | 0.220 |
Why?
|
| Gangliosidosis, GM1 | 1 | 2025 | 24 | 0.220 |
Why?
|
| Learning | 1 | 2006 | 184 | 0.220 |
Why?
|
| Tumor Burden | 2 | 2022 | 73 | 0.220 |
Why?
|
| Case-Control Studies | 5 | 2025 | 1131 | 0.200 |
Why?
|
| Parents | 2 | 2004 | 395 | 0.200 |
Why?
|
| Adolescent | 8 | 2025 | 6306 | 0.200 |
Why?
|
| Epilepsy | 1 | 2024 | 110 | 0.190 |
Why?
|
| Hand | 2 | 2020 | 75 | 0.190 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 358 | 0.190 |
Why?
|
| Genetic Vectors | 2 | 2025 | 887 | 0.190 |
Why?
|
| Dependovirus | 2 | 2025 | 718 | 0.180 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2022 | 26 | 0.180 |
Why?
|
| Neck | 2 | 2018 | 45 | 0.170 |
Why?
|
| Diagnosis, Differential | 2 | 2014 | 984 | 0.160 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 178 | 0.160 |
Why?
|
| Infant | 5 | 2025 | 1664 | 0.160 |
Why?
|
| Contrast Media | 2 | 2020 | 429 | 0.150 |
Why?
|
| Motor Cortex | 1 | 2020 | 71 | 0.150 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 6 | 0.140 |
Why?
|
| Thumb | 1 | 2018 | 27 | 0.140 |
Why?
|
| Functional Laterality | 1 | 2019 | 138 | 0.140 |
Why?
|
| Antigens, CD19 | 1 | 2018 | 25 | 0.140 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2018 | 23 | 0.140 |
Why?
|
| Young Adult | 5 | 2025 | 4782 | 0.140 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2018 | 74 | 0.140 |
Why?
|
| Reproducibility of Results | 3 | 2025 | 1682 | 0.140 |
Why?
|
| Adoptive Transfer | 1 | 2018 | 149 | 0.140 |
Why?
|
| Neural Pathways | 1 | 2018 | 102 | 0.140 |
Why?
|
| Cytokines | 2 | 2021 | 945 | 0.140 |
Why?
|
| Lymphoma | 1 | 2018 | 103 | 0.140 |
Why?
|
| Prognosis | 4 | 2024 | 1769 | 0.130 |
Why?
|
| Aged | 9 | 2024 | 14663 | 0.130 |
Why?
|
| Cavernous Sinus Thrombosis | 1 | 2016 | 2 | 0.130 |
Why?
|
| Nose Diseases | 1 | 2016 | 9 | 0.130 |
Why?
|
| Orbital Diseases | 1 | 2016 | 10 | 0.130 |
Why?
|
| Pharyngeal Diseases | 1 | 2016 | 11 | 0.130 |
Why?
|
| Meninges | 1 | 2016 | 10 | 0.130 |
Why?
|
| Mouth Diseases | 1 | 2016 | 13 | 0.120 |
Why?
|
| Cerebral Angiography | 2 | 2015 | 295 | 0.120 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 2621 | 0.120 |
Why?
|
| Preoperative Care | 1 | 2017 | 199 | 0.120 |
Why?
|
| Biomarkers | 1 | 2022 | 1431 | 0.120 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 174 | 0.120 |
Why?
|
| Prostheses and Implants | 1 | 2016 | 71 | 0.120 |
Why?
|
| Adipose Tissue | 1 | 2018 | 297 | 0.120 |
Why?
|
| Critical Pathways | 1 | 2015 | 33 | 0.110 |
Why?
|
| Petrous Bone | 1 | 2014 | 3 | 0.110 |
Why?
|
| Intelligence | 2 | 2005 | 52 | 0.110 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2014 | 7 | 0.110 |
Why?
|
| Cochlear Nerve | 1 | 2014 | 8 | 0.110 |
Why?
|
| Mastoid | 1 | 2014 | 9 | 0.110 |
Why?
|
| Ear, Inner | 1 | 2014 | 17 | 0.110 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2014 | 49 | 0.100 |
Why?
|
| Oxygen | 2 | 2018 | 321 | 0.100 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 1019 | 0.100 |
Why?
|
| Follow-Up Studies | 3 | 2024 | 2482 | 0.100 |
Why?
|
| Aged, 80 and over | 3 | 2024 | 5528 | 0.090 |
Why?
|
| Prospective Studies | 4 | 2020 | 3318 | 0.090 |
Why?
|
| Disease Progression | 3 | 2025 | 1174 | 0.090 |
Why?
|
| Caroli Disease | 1 | 2011 | 1 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 695 | 0.090 |
Why?
|
| Hamartoma | 1 | 2011 | 12 | 0.090 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 1164 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2010 | 2605 | 0.080 |
Why?
|
| Ileum | 1 | 2010 | 21 | 0.080 |
Why?
|
| Cell Transplantation | 1 | 2009 | 39 | 0.080 |
Why?
|
| Acidosis | 1 | 2010 | 27 | 0.080 |
Why?
|
| Urologic Surgical Procedures | 1 | 2010 | 44 | 0.080 |
Why?
|
| Survival Rate | 2 | 2024 | 859 | 0.080 |
Why?
|
| Dyslexia | 1 | 2009 | 8 | 0.080 |
Why?
|
| Intelligence Tests | 1 | 2009 | 26 | 0.080 |
Why?
|
| Language Development | 1 | 2009 | 10 | 0.080 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2009 | 30 | 0.070 |
Why?
|
| Colon | 1 | 2010 | 149 | 0.070 |
Why?
|
| Optic Chiasm | 1 | 2008 | 6 | 0.070 |
Why?
|
| Leukodystrophy, Globoid Cell | 1 | 2008 | 4 | 0.070 |
Why?
|
| Optic Nerve | 1 | 2008 | 25 | 0.070 |
Why?
|
| Optic Nerve Diseases | 1 | 2008 | 18 | 0.070 |
Why?
|
| Aging | 1 | 2014 | 754 | 0.070 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2009 | 178 | 0.070 |
Why?
|
| Nanostructures | 1 | 2009 | 181 | 0.060 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 2006 | 6 | 0.060 |
Why?
|
| Fornix, Brain | 1 | 2006 | 11 | 0.060 |
Why?
|
| Red Nucleus | 1 | 2025 | 5 | 0.060 |
Why?
|
| Basal Ganglia | 1 | 2025 | 34 | 0.060 |
Why?
|
| beta-Hexosaminidase alpha Chain | 1 | 2025 | 14 | 0.060 |
Why?
|
| Orientation | 1 | 2005 | 26 | 0.060 |
Why?
|
| Self-Assessment | 1 | 2005 | 60 | 0.060 |
Why?
|
| Thalamic Nuclei | 1 | 2025 | 25 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2016 | 5696 | 0.060 |
Why?
|
| Amygdala | 1 | 2025 | 84 | 0.060 |
Why?
|
| Culture | 1 | 2005 | 80 | 0.060 |
Why?
|
| Personality Assessment | 1 | 2004 | 29 | 0.060 |
Why?
|
| Atrophy | 1 | 2025 | 87 | 0.060 |
Why?
|
| White Matter | 1 | 2025 | 123 | 0.050 |
Why?
|
| Central Nervous System Diseases | 1 | 2024 | 58 | 0.050 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2024 | 68 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2009 | 629 | 0.050 |
Why?
|
| Perception | 1 | 2004 | 178 | 0.050 |
Why?
|
| Attention | 1 | 2005 | 148 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2005 | 788 | 0.050 |
Why?
|
| Achievement | 1 | 2002 | 29 | 0.050 |
Why?
|
| Faculty | 1 | 2002 | 55 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2024 | 322 | 0.050 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 2021 | 3 | 0.040 |
Why?
|
| Cognition | 1 | 2005 | 491 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 457 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1272 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2002 | 1105 | 0.040 |
Why?
|
| Age Factors | 1 | 2003 | 1570 | 0.040 |
Why?
|
| Time Factors | 2 | 2018 | 3725 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 1561 | 0.040 |
Why?
|
| Carcinoma, Large Cell | 1 | 2018 | 5 | 0.040 |
Why?
|
| Body Water | 1 | 2018 | 15 | 0.040 |
Why?
|
| Probability | 1 | 2018 | 169 | 0.030 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2018 | 59 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2018 | 93 | 0.030 |
Why?
|
| Comorbidity | 1 | 2021 | 1119 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1020 | 0.030 |
Why?
|
| United States | 2 | 2017 | 7923 | 0.030 |
Why?
|
| Artifacts | 1 | 2018 | 127 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2004 | 2738 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2018 | 181 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2018 | 291 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2018 | 248 | 0.030 |
Why?
|
| Head | 1 | 2016 | 54 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 259 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 356 | 0.030 |
Why?
|
| Collateral Circulation | 1 | 2014 | 26 | 0.030 |
Why?
|
| Animals | 3 | 2024 | 20955 | 0.030 |
Why?
|
| Observer Variation | 1 | 2014 | 215 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2014 | 183 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2014 | 421 | 0.020 |
Why?
|
| Porosity | 1 | 2009 | 40 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2014 | 1375 | 0.020 |
Why?
|
| Anisotropy | 1 | 2009 | 63 | 0.020 |
Why?
|
| Membranes, Artificial | 1 | 2009 | 46 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2009 | 240 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2008 | 30 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 608 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2009 | 487 | 0.020 |
Why?
|
| Radiography | 1 | 2008 | 553 | 0.020 |
Why?
|
| Rats | 1 | 2009 | 2005 | 0.010 |
Why?
|
| Incidence | 1 | 2010 | 1386 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2009 | 2177 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 2005 | 218 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2005 | 397 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 3449 | 0.010 |
Why?
|
| Mice | 1 | 2009 | 10994 | 0.010 |
Why?
|